3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma, Kaposi
1
Acquired Immunodeficiency Syndrome
1
Interventions
Zidovudine
10
Doxorubicin
10
Vincristine
7
Bleomycin
7
Liposomes
5
Interferon alpha-2
5
tecogalan
4
Etoposide
3
sargramostim
2
pomalidomide
2
liposomal doxorubicin
2
interferon alfa-n1
2
Valganciclovir
2
Ritonavir
2
Paclitaxel
2
Nivolumab
2
Mitoxantrone
2
Didanosine
2
vesnarinone
1
tocilizumab
1
tin etiopurpurin
1
abemaciclib
1
Zalcitabine
1
Tumor Necrosis Factor-alpha
1
Sorafenib
1
Semaxinib
1
Ro 24-7429
1
O-(Chloroacetylcarbamoyl)fumagillol
1
Nevirapine
1
Muromonab-CD3
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Acquired Immunodeficiency Syndrome
×
Nevirapine
×
Sarcoma
×
Clear all
NCT00380770
2010-07-21
KAART
University of KwaZulu
Phase 4
Completed
112 enrolled